Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer

PURPOSE: We sought to investigate the safety and efficacy of gemcitabine, cisplatin, and lapatinib (GCL) as neoadjuvant therapy in patients with muscle-invasive bladder cancer (MIBC) planned for radical cystectomy. MATERIALS AND METHODS: Four cycles of GCL were administered as neoadjuvant therapy fo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Res Treat
Egile Nagusiak: Narayan, Vivek, Mamtani, Ronac, Keefe, Stephen, Guzzo, Thomas, Malkowicz, S. Bruce, Vaughn, David J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Korean Cancer Association 2016
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4946374/
https://ncbi.nlm.nih.gov/pubmed/26639198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2015.405
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak